Free Access
Issue |
Analusis
Volume 26, Number 8, October 1998
Chemometrics 98
|
|
---|---|---|
Page(s) | 277 - 280 | |
Section | Original articles | |
DOI | https://doi.org/10.1051/analusis:1998173 |
Analusis 26, 277-280 (1998)
DOI: 10.1051/analusis:1998173
1 Laboratoire de Technique Pharmaceutique Industrielle, Faculté de Pharmacie, Avenue C. Flahault, 34060 Montpellier Cedex, France
2 L.E.P.M.I.,Laboratoire de Chimie Analytique, Faculté de Pharmacie, Avenue C. Flahault, 34060 Montpellier Cedex, France
Key words: Preformulation / suspension / experimental design / central composite design.
© EDP Sciences, Wiley-VCH 1998
DOI: 10.1051/analusis:1998173
Formulation of insoluble drugs. Study of pharmaceutical suspensions by response surface methodology
F. Nielloud1, G. Marti-Mestres1, R. Fortuné1, J.P. Mestres2 and H. Maillols11 Laboratoire de Technique Pharmaceutique Industrielle, Faculté de Pharmacie, Avenue C. Flahault, 34060 Montpellier Cedex, France
2 L.E.P.M.I.,Laboratoire de Chimie Analytique, Faculté de Pharmacie, Avenue C. Flahault, 34060 Montpellier Cedex, France
Abstract
The preformulation of insoluble drugs, sulfadiazine and aluminium hydroxyde, were studied in order to achieve a suspension with desirable requirements. The objective of the formulator is to avoid
the irreversible aggregation called "caking", and to obtain a suspension with an airy, large volume sediment easily redispersible and with suitable rheological properties. An experimental design
useful to determine optimal properties is a Central Composite Design. The surfactant, thickener and electrolyte at different proportions are the 3 factors studied. This strategy allows to point on
the main significant effect and to determine the concentrations of each product leading to optimal properties of the suspensions.
Key words: Preformulation / suspension / experimental design / central composite design.
© EDP Sciences, Wiley-VCH 1998